Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle
- PMID: 24994560
- PMCID: PMC4223487
- DOI: 10.1074/mcp.M113.032276
Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle
Abstract
Congenital muscular dystrophy with laminin α2 chain deficiency (MDC1A) is one of the most severe forms of muscular disease and is characterized by severe muscle weakness and delayed motor milestones. The genetic basis of MDC1A is well known, yet the secondary mechanisms ultimately leading to muscle degeneration and subsequent connective tissue infiltration are not fully understood. In order to obtain new insights into the molecular mechanisms underlying MDC1A, we performed a comparative proteomic analysis of affected muscles (diaphragm and gastrocnemius) from laminin α2 chain-deficient dy(3K)/dy(3K) mice, using multidimensional protein identification technology combined with tandem mass tags. Out of the approximately 700 identified proteins, 113 and 101 proteins, respectively, were differentially expressed in the diseased gastrocnemius and diaphragm muscles compared with normal muscles. A large portion of these proteins are involved in different metabolic processes, bind calcium, or are expressed in the extracellular matrix. Our findings suggest that metabolic alterations and calcium dysregulation could be novel mechanisms that underlie MDC1A and might be targets that should be explored for therapy. Also, detailed knowledge of the composition of fibrotic tissue, rich in extracellular matrix proteins, in laminin α2 chain-deficient muscle might help in the design of future anti-fibrotic treatments. All MS data have been deposited in the ProteomeXchange with identifier PXD000978 (http://proteomecentral.proteomexchange.org/dataset/PXD000978).
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.
Figures
Similar articles
-
Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy.Sci Rep. 2017 Mar 10;7:44059. doi: 10.1038/srep44059. Sci Rep. 2017. PMID: 28281577 Free PMC article.
-
Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice.Hum Mol Genet. 2011 Feb 1;20(3):541-52. doi: 10.1093/hmg/ddq499. Epub 2010 Nov 17. Hum Mol Genet. 2011. PMID: 21084425
-
Exon Skipping Using Antisense Oligonucleotides for Laminin-Alpha2-Deficient Muscular Dystrophy.Methods Mol Biol. 2018;1828:553-564. doi: 10.1007/978-1-4939-8651-4_36. Methods Mol Biol. 2018. PMID: 30171567
-
Laminin-α2 Chain-Deficient Congenital Muscular Dystrophy: Pathophysiology and Development of Treatment.Curr Top Membr. 2015;76:31-60. doi: 10.1016/bs.ctm.2015.05.002. Curr Top Membr. 2015. PMID: 26610911 Review.
-
Merosin and congenital muscular dystrophy.Microsc Res Tech. 2000 Feb 1-15;48(3-4):181-91. doi: 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q. Microsc Res Tech. 2000. PMID: 10679965 Review.
Cited by
-
Vemurafenib improves muscle histopathology in a mouse model of LAMA2-related congenital muscular dystrophy.Dis Model Mech. 2023 Jun 1;16(6):dmm049916. doi: 10.1242/dmm.049916. Epub 2023 May 10. Dis Model Mech. 2023. PMID: 37021539 Free PMC article.
-
Extracellular matrix: an important regulator of cell functions and skeletal muscle development.Cell Biosci. 2021 Mar 31;11(1):65. doi: 10.1186/s13578-021-00579-4. Cell Biosci. 2021. PMID: 33789727 Free PMC article. Review.
-
212th ENMC International Workshop: Animal models of congenital muscular dystrophies, Naarden, The Netherlands, 29-31 May 2015.Neuromuscul Disord. 2016 Mar;26(3):252-9. doi: 10.1016/j.nmd.2016.02.002. Epub 2016 Feb 15. Neuromuscul Disord. 2016. PMID: 26948708 Free PMC article. No abstract available.
-
Laminin-α2 chain deficiency in skeletal muscle causes dysregulation of multiple cellular mechanisms.Life Sci Alliance. 2024 Oct 8;7(12):e202402829. doi: 10.26508/lsa.202402829. Print 2024 Dec. Life Sci Alliance. 2024. PMID: 39379105 Free PMC article.
-
Antioxidants Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy.Antioxidants (Basel). 2020 Mar 18;9(3):244. doi: 10.3390/antiox9030244. Antioxidants (Basel). 2020. PMID: 32197453 Free PMC article.
References
-
- Allamand V., Guicheney P. (2002) Merosin-deficient muscular dystrophy, autosomal recessive (MDC1A, MIM#156225, LAMA2 gene coding for α2 chain of laminin). Eur. J. Hum. Genet. 10, 91–94 - PubMed
-
- Helbling-Leclerc A., Zhang X., Topaloglu H., Cruaud C., Tesson F., Weissenbach J., Tomé F. M. S., Schwartz K., Fardeau M., Tryggvason K., Guicheney P. (1995) Mutations in the laminin α2 chain gene (LAMA2) cause merosin-deficient muscular dystrophy. Nat. Genet. 11, 216–218 - PubMed
-
- Voit T., Tomé F. S. (2004) The congenital muscular dystrophies. In Myology (Angel A., Franzini-Armstrong C., eds) Vol. 2, pp. 1203–1238, McGraw-Hill, New York
-
- Ibraghimov-Beskrovnaya O., Ervasti J. M., Leveille C. J., Slaughter C. A., Sernett S. W., Campbell K. P. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355, 696–702 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources